CF
ETNB

Cantor Fitzgerald’s 89bio ETNB Stock Holding History

Cantor Fitzgerald’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-267,606
Closed -$3.93M – 263
2025
Q3 		$3.93M Buy
+267,606
New +$2.73M 0.04% 124

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cantor Fitzgerald's ETNB Position: Q4 2025 in Review

Cantor Fitzgerald sold out of 89bio (ETNB) in Q4 2025, closing a stake of 267,606 shares — an estimated $3.93M sold.

Cantor Fitzgerald first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $3.93M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Cantor Fitzgerald reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 267,606 89bio shares in Q4 2025, an estimated $3.93M.
  • Cantor Fitzgerald first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Cantor Fitzgerald's 89bio position peaked at $3.93M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Cantor Fitzgerald's 13F filing for Q4 2025, filed 17 Feb 2026.